Use of Cryopressotherapy in Patiens Undergoing Total Knee Replacement to Improve Clinical Outcome (CRYO-KNEE)

The purpose of this study is to evaluate the effectiveness of cryopressotherapy in patients undergoing total knee arthroplasty by assessing clinical improvement using the KOOS at 14 days after surgery.

Analysis of the knee Range of Motion (ROM) in the preoperative phase, at the predischarge visit, and at the follow-up visit for suture removal performed 14 days after surgery.

Analysis of PROMs such as: Oxford Knee Score (OKS), Joint Forgotten (JF), NRS score, and SF-12.

These questionnaires will be collected in the preoperative phase, at the predischarge visit, and at the follow-up visit for suture removal performed 14 days after surgery.

To evaluate whether cryopressotherapy leads to an improvement in predischarge hemoglobin (Hb) levels.

To assess whether cryopressotherapy reduces the circumference and subcutaneous fluid accumulation of the operated limb.

Study Overview

Detailed Description

Knee osteoarthritis is a degenerative condition that causes cartilage wear, leading to pain, stiffness, and difficulty moving. It mainly affects older adults, but it can also occur in younger individuals in cases of genetic predisposition or trauma. Symptoms include pain during or after physical activity, swelling, and difficulty walking.

Initial treatment is based on physiotherapy, anti-inflammatory medications, and injections, but if the disease progresses, a total knee replacement with a prosthesis may become necessary. Modern prostheses are made with advanced materials and minimally invasive surgical techniques, improving postoperative recovery.

Using ice in the first few days after surgery is crucial to reducing pain and swelling, improving functional recovery, and lowering the need for pain medications, such as opioids. Moreover, ice therapy promotes early rehabilitation and reduces hospitalization time. Cryotherapy may also help lower healthcare costs thanks to more effective pain management.

Advanced continuous cooling devices, although promising, require further studies to confirm their effectiveness.

The aim of the study is therefore to assess whether the cryopressotherapy protocol leads to an improvement in clinical outcomes in patients undergoing total knee arthroplasty (TKA), earlier mobilization, and reduced use of pain medication.

Study Type

Interventional

Enrollment (Estimated)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Italy
      • Milan, Italy, Italy, 20157
        • Recruiting
        • IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Milan 20173
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Candidates for elective total knee arthroplasty surgery (indication determined solely by the Orthopedic Surgeon)
  • Patients aged between 18 and 80 years (inclusive) for both groups
  • Body Mass Index (BMI) between 18 and 35 kg/m²
  • Willingness and ability to provide informed consent
  • Patients with non-inflammatory degenerative knee joint disease, including osteoarthritis

Exclusion Criteria:

  • Use of medications that may interfere with muscle metabolism
  • Bone metastases or diseases at the surgical site
  • Presence or suspicion of infection at the knee
  • Inability to provide informed consent
  • Obesity (BMI ≥ 35 kg/m²)
  • Patients requiring revision surgery of total knee arthroplasty
  • Patients with pacemakers and/or mechanical implants or those who may be affected by BIA interference

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: will undergo a cryopressotherapy protocol using a dedicated device/machine.
Cryopressotherapy treatment (using the device) consists of applying the machine in 6-hour cycles per day, to be performed 3 hours in the morning and 3 hours in the afternoon during the 4 days after surgery.
Comparison between Cryopressotherapy and ice pack in patients undergoing Total Knee Arthroplasty to improve clinical outcomes
Active Comparator: Group B: will undergo a cryotherapy protocol using ice.
Cryotherapy (i.e., cold therapy) consists of applying local ice using an ice pack 3 times per day, with 1-hour applications alternating 15 minutes on and 15 minutes off during the first 4 days after surgery.
Comparison between ice pack and cryopressotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 14 Days Postoperatively
Time Frame: Preoperative assessment and 14 days postoperatively.

The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported questionnaire consisting of 5 subscales: Pain, Symptoms, Activities of Daily Living (ADL), Sport and Recreation Function, and Knee-Related Quality of Life.

Each subscale is scored separately and transformed to a 0-100 scale, where 0 represents extreme knee problems and 100 represents no knee problems.

The outcome measure is the change from preoperative baseline to 14 days postoperatively in KOOS scores

Preoperative assessment and 14 days postoperatively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis of the knee Range of Motion (ROM) in the preoperative phase
Time Frame: Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit).
Knee range of motion (ROM) measured in degrees using a goniometer. Flexion and extension will be recorded. Higher flexion values indicate better joint mobility, while lower extension deficit values indicate better functional outcome.
Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit).
Analysis of PROMs (Patient-Reported Outcome Measures): Oxford Knee Score (OKS)
Time Frame: Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit).
The Oxford Knee Score (OKS) is a 12-item patient-reported outcome measure assessing pain and function in patients undergoing knee surgery. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating better knee function.
Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit).
Analysis of PROMs (Patient-Reported Outcome Measures): Forgotten Joint Score (FJS-12)
Time Frame: Pre-discharge visit; 14 days postoperatively (suture removal visit).
The Forgotten Joint Score-12 (FJS-12) is a 12-item questionnaire evaluating joint awareness during daily activities. Scores range from 0 to 100, with higher scores indicating better outcome and less joint awareness.
Pre-discharge visit; 14 days postoperatively (suture removal visit).
Analysis of PROMs (Patient-Reported Outcome Measures): Numerical Rating Scale (NRS) for pain
Time Frame: Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit)
Pain intensity measured using an 11-point Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain)
Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit)
Analysis of PROMs (Patient-Reported Outcome Measures): Short Form-12 Health Survey (SF-12)
Time Frame: Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit)
The Short Form-12 (SF-12) is a validated questionnaire assessing health-related quality of life. It provides a Physical Component Summary (PCS) and a Mental Component Summary (MCS). Higher scores indicate better health status
Preoperative assessment; pre-discharge visit; 14 days postoperatively (suture removal visit)
Improvement in hemoglobin (Hb) levels
Time Frame: Preoperative assessment and pre-discharge visit
Hemoglobin (Hb) levels measured in g/dL through standard blood testing. The change from preoperative baseline to postoperative assessment will be evaluated. Higher postoperative Hb levels indicate reduced blood loss.
Preoperative assessment and pre-discharge visit
Change in operated limb circumference
Time Frame: Preoperative assessment; pre-discharge visit; 14 days postoperatively.
Operated limb circumference measured in centimeters (cm) using a measuring tape at standardized anatomical reference points. The change from preoperative baseline will be calculated. A reduction in circumference indicates decreased postoperative swelling.
Preoperative assessment; pre-discharge visit; 14 days postoperatively.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Mangiavini, University of Milan, IRCCS Ospedale Galeazzi-Sant'Ambrogio

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2025

Primary Completion (Actual)

October 13, 2025

Study Completion (Estimated)

February 1, 2028

Study Registration Dates

First Submitted

January 8, 2026

First Submitted That Met QC Criteria

March 3, 2026

First Posted (Actual)

March 6, 2026

Study Record Updates

Last Update Posted (Actual)

March 6, 2026

Last Update Submitted That Met QC Criteria

March 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CRYO-KNEE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty\(TKA\)

Subscribe